Thx to you both on this Dr Brem work and what it could mean. If Dr Brem has been able to compare GBM biomarkers from a validated database of patients vs the DCVax-L treated patients it would constitute possible additional strong support, the type of which BP's tend to work up for their submissions and the type of which RA's are interested in.
Market Data 
Markets 
AI
